Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction.

Morales-Ponce, Francisco JGonzález-Pérez, PabloBlasco-Turrión, SaraSánchez-Brotons, Juan AntonioCollado-Moreno, CarmenMartínez-Romero, PedroMartínez-Morentín, EduardoCaro-Mateo, Pilar2023-02-092023-02-092021-01-13http://hdl.handle.net/10668/16966enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/AbciximabFibrinolytic AgentsHumansImmunoglobulin Fab FragmentsMyocardial InfarctionPlatelet Aggregation InhibitorsTenecteplaseTreatment OutcomeVentricular FunctionEffects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction.research article33438179open access10.5603/CJ.a2021.00021898-018XPMC8105071https://journals.viamedica.pl/cardiology_journal/article/download/CJ.a2021.0002/52966https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105071/pdf